Silverstein R L, Leung L L, Harpel P C, Nachman R L
J Clin Invest. 1985 Jun;75(6):2065-73. doi: 10.1172/JCI111926.
Thrombospondin (TSP), a multifunctional alpha-granule glycoprotein of human platelets binds fibrinogen, fibronectin, heparin, histidine-rich glycoprotein (HRGP), and plasminogen (Plg), and thus, may play an important role in regulating thrombotic influences at vessel surfaces. In this study we have demonstrated that purified human platelet TSP formed a trimolecular complex with human Plg and HRGP. Complex formation was detected by a specific binding enzyme-linked immunosorbent assay (ELISA) which demonstrated simultaneous binding of fluid-phase Plg and HRGP to TSP adsorbed to microtitration wells. While neither ligand inhibited complex formation of the other with TSP, 10 mM epsilon-amino-n-caproic acid selectively blocked incorporation of Plg into the complex, suggesting that TSP contains independent binding sites for Plg and HRGP. Comparable extent of trimolecular complex formation was also detected when TSP monomer was substituted for whole TSP in the ELISA. HRGP covalently cross-linked to Sepharose 4B simultaneously bound both 125I-TSP and 131I-Plg, confirming trimolecular complex formation. Rocket immunoelectrophoresis of mixtures of the purified radiolabeled proteins into anti-Plg containing agarose also confirmed trimolecular complex formation. The TSP-HRGP-Plg complex bound a similar amount of heparin as the TSP-HRGP complex, demonstrating that the HRGP within the trimolecular complex maintained functional capability. Similarly, using a fluorometric plasmin substrate, the trimolecular complex was shown to be an effective substrate for tissue plasminogen activator. Significant amounts of plasmin were generated from the TSP-HRGP-Plg complex (equivalent to that from the TSP-Plg complex), but the rate of plasmin generation from the trimolecular complex was greater than from the bimolecular complex, suggesting an important interaction of HRGP with Plg when both are complexed to TSP. The macromolecular assembly of these three proteins on cellular surfaces, such as the platelet, may serve important regulatory functions, both prothrombotic at sites of active fibrin deposition and proteolytic in nonfibrin-containing microenvironments.
血小板反应蛋白(TSP)是人类血小板中的一种多功能α颗粒糖蛋白,它能结合纤维蛋白原、纤连蛋白、肝素、富含组氨酸的糖蛋白(HRGP)和纤溶酶原(Plg),因此可能在调节血管表面的血栓形成影响方面发挥重要作用。在本研究中,我们已证明纯化的人类血小板TSP与人类Plg和HRGP形成了三分子复合物。通过特异性结合酶联免疫吸附测定(ELISA)检测到复合物的形成,该测定表明液相Plg和HRGP同时与吸附在微量滴定孔上的TSP结合。虽然两种配体均未抑制彼此与TSP形成复合物,但10 mM ε-氨基-n-己酸选择性地阻止了Plg掺入复合物,这表明TSP含有与Plg和HRGP独立的结合位点。当在ELISA中用TSP单体替代完整TSP时,也检测到了相当程度的三分子复合物形成。与琼脂糖凝胶4B共价交联的HRGP同时结合了125I-TSP和131I-Plg,证实了三分子复合物的形成。将纯化的放射性标记蛋白混合物进行火箭免疫电泳进入含抗Plg的琼脂糖中也证实了三分子复合物的形成。TSP-HRGP-Plg复合物结合的肝素量与TSP-HRGP复合物相似,表明三分子复合物中的HRGP保持了功能能力。同样,使用荧光纤溶酶底物,三分子复合物被证明是组织纤溶酶原激活剂的有效底物。从TSP-HRGP-Plg复合物中产生了大量纤溶酶(与从TSP-Plg复合物中产生的量相当),但三分子复合物中纤溶酶的产生速率大于双分子复合物,这表明当Plg和HRGP都与TSP复合时,HRGP与Plg之间存在重要相互作用。这三种蛋白质在细胞表面(如血小板)的大分子组装可能发挥重要的调节功能,在活跃纤维蛋白沉积部位具有促血栓形成作用,而在不含纤维蛋白的微环境中具有蛋白水解作用。